Latest Asx News

Pivotal Metals has identified a promising new copper-gold exploration target, Kelly Lake East, within its Belleterre project in Quebec, setting the stage for a major drilling campaign in early 2026.

DevEx Resources reports a major metallurgical breakthrough at its Kennedy Rare Earths Project in Queensland, achieving up to 68% recovery of critical magnet rare earth elements using a straightforward heap leach process with low acid consumption.

West Coast Silver’s latest drilling at Elizabeth Hill confirms additional near-surface silver mineralisation and suggests a larger, vertically continuous system extending below historical workings. Assay results are expected soon, underpinning the project’s significant exploration potential.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its clinical trial for PYC-003, an RNA therapy targeting Polycystic Kidney Disease. This milestone moves the drug closer to pivotal Phase 2/3 trials.

Basin Energy has agreed to sell its Marshall Uranium Project to Green Canada Corporation, securing cash, shares, and a significant equity stake while retaining strategic rights and exposure to Canadian uranium assets.

The a2 Milk Company has secured key regulatory approvals in China, moving closer to launching its infant formula products under the a2MC brand by mid-2027.

Sunshine Metals Limited will lift its trading suspension on 24 November 2025 following a key Supreme Court ruling. Investors await details on the court outcome that triggered the suspension.

Atomic Eagle Ltd, formerly known as Tombador Iron Limited, will have its trading suspension lifted and be reinstated to quotation on the ASX starting 24 November 2025 after meeting key compliance requirements.

Infomedia Ltd shares will halt trading following the Supreme Court of NSW's approval of a takeover scheme by a TPG Capital-backed entity. This marks a pivotal moment for the software company as it transitions to private ownership.

Aurumin Limited’s shares will be suspended from trading following court approval of Brightstar Resources’ acquisition scheme, marking a pivotal step in the takeover process.

WAM Income Maximiser Limited has confirmed its fully franked ordinary dividend for November 2025 and updated the Dividend Reinvestment Plan price, providing clarity for investors ahead of the payment date.

The Foreign Investment Review Board has formally objected to Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma, casting serious doubt on the deal’s future and prompting Mayne to explore alternative paths.